For decades, maternity care in the United States has been reimbursed primarily through a single global obstetric code, bundling antepartum care, labor and delivery, and postpartum services into one payment. While administratively straightforward, this structure has increasingly failed to reflect contemporary obstetric practice, which is more team‑based, fragmented, and clinically complex than when the global codes were first designed. Beginning January 1, 2027, that paradigm will shift.
The American Medical Association (AMA), in collaboration with ACOG and other specialty societies, has finalized a major restructuring of CPT maternity care services. The CPT 2027 framework replaces the legacy bundled model with service‑level reporting across four phases of care: antepartum, labor management, delivery, and postpartum. The intent is to align payment with real‑world obstetric care delivery, while improving transparency and attribution across the full pregnancy continuum.
At a national policy level, CMS and the AMA have been clear: the CPT 2027 maternity care revisions are expected to be budget neutral. Survey data from more than 650 obstetricians, family physicians, and certified nurse midwives were used by the RVS Update Committee (RUC) to assess physician time, intensity, and complexity. The resulting work RVU recommendations were structured so that, in aggregate, total RVUs generated under the new code set do not exceed those produced by the former global maternity codes.
However, budget neutrality at the system level does not translate into neutral impact for individual clinicians or practices. The new structure redistributes revenue based on how care is delivered, how frequently patients are seen, and how well practices adapt documentation, coding, and workflow. As a result, some obstetricians may experience improved revenue capture, while others could see downward pressure if operational changes are not made.
Under the global code model, most reimbursement flowed at the time of delivery, regardless of the complexity, duration, or fragmentation of care provided during pregnancy. This approach favored continuity models but often resulted in uncompensated work for physicians managing prolonged labor, caring for transferred patients, or providing postpartum follow‑up outside the traditional bundle.
CPT 2027 introduces a more detailed and differentiated approach. Antepartum and postpartum care will be reported using standard E/M codes on a per‑encounter basis. Labor management is reported daily, with distinctions between initial and subsequent days and between straightforward and complex management. Delivery codes are streamlined and now represent delivery services only, independent of labor management or postpartum care. This structure allows reimbursement to more closely follow physician work and patient acuity across time.
For some obstetricians, the CPT 2027 framework may improve alignment between effort and payment. Practices operating in team‑based or fragmented care environments—such as Hospitalist models, hospital‑employed groups, and tertiary referral centers—are likely to see improved revenue attribution. Under the global code system, much of this work was either unpaid or imperfectly recognized.
High‑acuity practices may also benefit. Prolonged inductions, extended labor courses, and complex clinical decision‑making can now be reflected through daily labor management codes rather than absorbed into a single bundled payment. Similarly, postpartum care, historically under‑recognized, becomes billable as discrete E/M services, potentially improving reimbursement for practices that prioritize postpartum follow‑up.
Not all obstetric practices will benefit equally. Traditional private practices providing comprehensive care for predominantly low‑risk patients may find that some of the financial buffering inherent in global codes is lost. Reimbursement becomes more sensitive to visit frequency, E/M level selection, and documentation accuracy.
Operational readiness will be critical. Unlike global codes, which offered some insulation against under‑coding, the CPT 2027 structure requires consistent, accurate service‑level reporting. Missed visits, under‑coded E/M services, or inconsistent labor management documentation could result in revenue loss rather than redistribution.
One notable advantage of CPT 2027 is the potential for more predictable cash flow. Instead of receiving the bulk of maternity‑related reimbursement at delivery, practices will receive payments incrementally across pregnancy and the postpartum period. This shift may reduce revenue volatility, mitigate losses related to patient transfers, and improve financial stability, particularly for independent groups.
Ultimately, CPT 2027 reflects a broader recognition that obstetric care is longitudinal, team‑based, and increasingly complex. While final CMS RVU values will not be published until late 2026, the trajectory is clear. Practices that engage early in education, workflow redesign, and E/M optimization will be best positioned to adapt to the new payment model and minimize unintended financial disruption. CPT 2027 is designed to be budget neutral overall, but its impact will vary by practice model, patient acuity, and operational readiness. The transition represents a structural redistribution of maternity care reimbursement rather than a universal increase or decrease.
CPT® 2027 Maternity Care Services code changes | American Medical Association
ACOG: Payment for Obstetric Services
The contents of this Site, such as text, graphics, images, information obtained from The ObG Project’s licensors, and other material contained on the Site (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional legal or medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of information you have read on the Site!
If you think you may have a medical emergency, call your doctor or 911 immediately. The ObG Project does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site. Reliance on any information provided by The ObG Project, The ObG Project employees, others appearing on the Site at the invitation of The ObG Project, or other visitors to the Site is solely at your own risk.
The Site may contain health- or medical-related materials that are sexually explicit. If you find these materials offensive, you may not want to use our Site.
Children’s Privacy
We are committed to protecting the privacy of children. You should be aware that this Site is not intended or designed to attract children under the age of 13. We do not collect personally identifiable information from any child we reasonably believe is under the age of 13.
Are you an
ObG Insider?
Get specially curated clinical summaries delivered to your inbox every week for free
Exclusive Features:
Continue with ObGFirst™
Read the full article, unlock patient-friendly tools, and access subscriber resources across the site.
Get ObGFirst™ for only $9/mo
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
It appears you don't have enough CME Hours to take this Post-Test. We no longer offer Hours.
You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site
